In Saccharomyces cerevisiae 6 closely related proteins (Did2p, Vps2p, Vps24p, Vps32p, Vps60p, Vps20p) form part of the extended ESCRT III complex. This complex is required for the formation of multivesicular bodies and the degradation of internalized transmembrane receptor proteins. In contrast the human genome encodes 10 homologous proteins (CHMP1A (approved gene symbol PCOLN3), 1B, 2A, 2B, 3 (approved gene symbol VPS24), 4A, 4B, 4C, 5, and 6). In this study we have performed a series of protein interaction experiments to generate a more comprehensive picture of the human CHMP protein-interaction network. Our results describe novel interactions between known components of the human ESCRT III complex and identify a range of putative binding partners, which may indicate new ways in which the function of human CHMP proteins may be regulated. In particular, we show that two further MIT domain-containing proteins (AMSH/STAMBP and LOC129531) interact with multiple components of the human ESCRT III complex.
In eukaryotic cells the relative expression of surface receptors can be regulated through a process of selective internalization and degradation. In some cases receptor internalization is initiated by the addition of a cytoplasmic mono-ubiquitin tag [1] [2] [3] . Ubiquitinated receptors are first endocytosed into clathrin-coated vesicles, which fuse with tubular-sorting endosomes. In this compartment receptors are either recycled back to the plasma membrane or segregated into membrane domains, which bud internally to form luminal vesicles. Endosomes that contain multiple luminal vesicles are called multivesicular bodies (MVBs). In many cells MVBs fuse with lysosomes, or vacuoles in yeast, leading to the destruction of exposed protein domains. However, in some mammalian cells MVBs also serve more specialized functions.
In antigen-presenting cells MVBs form part of the major histocompatibility complex II (MHCII) compartments (MIICs), where MHCII is loaded with antigenic peptides [4] . In these cells MVBs fuse with the plasma membrane thereby delivering loaded MHCII molecules to the cell surface and releasing vesicles called exosomes from the cell [5] ; a variation of this process is also observed in dendritic cells [6] . Interestingly, in monocyte-derived macrophages HIV is known to utilize the MVB/MIIC compartment as a site of particle assembly [7, 8] . Also several of the proteins required for MVB formation are also needed for budding of HIV particles at the plasma membrane [9, 10] .
Much of our current understanding of MVB formation is derived from pioneering genetic studies performed in yeast. To date, more then 70 genes are known to be required for the transport of proteins into vacuoles. These vacuolar proteinsorting (VPS) genes have been grouped into six classes (A-F) based on the morphology of vacuoles observed in yeast mutants. The 18 class E VPS proteins are all required for efficient degradation of surface receptor proteins and the formation of MVBs [11, 12] . Biochemical analysis of yeast class E VPS mutants led to the proposal that class E proteins are organized into three complexes called ESCRT I, II, and III. In yeast the ESCRT I complex is thought to contain a single copy of Vps23p and multiple copies of Vps28p and Vps37p; in addition, Vps27p and Hse1p are also thought to be associated with this complex [2, 13, 14] . The yeast ESCRT II complex appears to be composed of three proteins: Vps22p, Vps25p, and Vps36p [15] . In contrast four proteins (Vps20p, Vps32, Vps24, and Vps2) appear to constitute the core of the ESCRT III complex [16, 17] , with Did2p and Vps60p possibly acting as peripheral auxiliary factors, which interact with the Vps4p/Vta1 complex [14, 18] , which in turn facilitates disassembly of the ESCRT III complex. A recent systematic study of protein interactions occurring between 17 soluble Class E proteins showed that these proteins are assembled into a single interconnected network. In addition this study demonstrated direct interaction between components of ESCRT I and ESCRT III [14] . As such, it is not yet clear if ESCRT complex assembly follows a conditional sequence or whether ESCRT I and III can function independent of ESCRT II.
Although many aspects of MVB formation appear to have been conserved through evolution, the precise function of individual mammalian ESCRT proteins and the basis for partner specificity remain unclear. The situation in human cells is further complicated by the fact that the human genome encodes 10 potential homologues of the six yeast ESCRT III proteins [10, 19] . These human proteins are referred to as CHMP1A (GeneID: 5119; approved gene symbol PCOLN3), CHMP1B (GeneID: 57132), CHMP2A (GeneID: 27243), CHMP2B (GeneID: 25978), CHMP3 (GeneID: 51652; approved gene symbol VPS24), CHMP4A (GeneID: 29082), CHMP4B (GeneID: 128866), CHMP4C (GeneID: 92421), CHMP5 (GeneID: 51510), and CHMP6 (GeneID: 79643). What role these additional mammalian components play in MVB formation is largely undefined.
Interestingly, several of the human CHMP proteins have both nuclear and cytoplasmic/vesicular distributions, and CHMP1A has been shown to be required for both MVB formation [19] and the regulation of cell cycle progression [20] . As yet it is not clear if other components of the human ESCRT III complex may also exhibit dual functionality.
A combination of targeted yeast two-hybrid and GST pulldown studies has been used to investigate interactions occurring between predicted components of the human ESCRT complexes [9, 10] . While these data provide a good insight into the potential organization of the human ESCRT complexes, there are still areas of data paucity and ambiguity. As yet, few interactions have been reported for the human CHMP5 protein. In part this is due to the potential of CHMP5 to autoactivate reporter expression in some yeast two-hybrid systems [9, 10] . Although interactions between known components of the mammalian ESCRT III complex have been studied in some detail, very few human CHMP proteins have been used as "baits" to screen high-complexity yeast twohybrid libraries. As such, our knowledge of subunit organization within the human ESCRT III complex and the identity of key auxiliary factors for both cytoplasmic and nuclear functions remain incomplete.
In this study we have performed a systematic yeast twohybrid analysis of all 10 human CHMP proteins. These data provide a more comprehensive insight into the complexity of the human CHMP protein interaction network and the occurrence of conserved "interlog" interactions. Finally data from 20 yeast two-hybrid library screens have identified a range of novel interaction partners, which may facilitate future characterization of novel pathway components and the mechanisms of CHMP protein function and regulation.
Results

Extended yeast two-hybrid analysis of human ESCRT III component interactions
In contrast to previous yeast two-hybrid studies [9, 10] we observed no autoactivation on SD-minus Trp/Leu/Ade plates with any of our (Ga14BD-X) CHMP bait constructs. This discrepancy with previous studies is most likely due to the high stringency of selection that is possible with the yeast two-hybrid system used in our assays [21] . This lack of autoactivation enabled us to perform comprehensive yeast two-hybrid studies with all 10 human CHMP proteins.
As the addition of large peptide domains is known to have dramatic effects on CHMP protein function [10] we thought it possible that some protein-protein interactions may be blocked by the addition of large N-terminal GAL4 domain fusions. To test this possibility we utilized a range of N-and C-terminal Gal4 bait and "prey" constructs ( Fig.  1A) to generate a more comprehensive insight into ESCRT III complex intersubunit interactions. The combined profile of protein interactions detected in these studies is shown in Figs. 1B-1D. In total we identified 25 subunit interactions (Fig. 1E ). Of these 15 were previously reported. However, 4 of the known interactions were previously detected only by non-yeast two-hybrid methods. In addition, we observed 9 novel interactions, including several interactions involving CHMP5 and CHMP2B, which were underrepresented in previous protein interaction studies. When C-terminal prey domain fusions (Y-Gal4AD) were screened against Nterminal bait constructs (Gal4BD-X) we observed significant homodimerization of several ESCRT III components, including Vps4A and CHMP 1A, 1B, 2A, 2B, 3, 4A, 4B, and 5 proteins (Fig. 1C) . Interestingly, CHMP4C and CHMP6 showed no sign of homodimerization under any of the conditions tested (Figs. 1B-1D ), although homodimerization of CHMP4C has been reported previously [9] .
In agreement with previous reports we also found that the MIT domain containing protein VPS4A interacts with multiple CHMP partners (1A, 1B, 2A, 4A, and 4B). However, we observed no interaction between VPS4A and CHMP 2B, 3, 4C, 5, or 6. Two previous yeast two-hybrid studies also failed to detect clear interactions between VPS4 and CHMP2B or CHMP3; however, both of these interactions were observed by GST pull-down methods [9] . Interestingly, no interaction has yet been detected between Vps4 and CHMP5.
As predicted several CHMP-CHMP interactions were detected only with specific combinations of GAL4-fusion constructs. This was particularly true for CHMP5, interactions of which with other ESCRT III components could be observed only when potential interaction partners were expressed in the N-terminal (Gal4AD-Y) prey format. In contrast CHMP5 homodimers were also observed when preys were expressed in C-terminal (Y-Gal4AD) prey format, suggesting that heterotypic interactions and homodimerization may have different requirements.
To identify novel auxiliary factors, we used each of the 10 human CHMP proteins as baits to screen two high-complexity human prey libraries derived from K562 cells and from fetal brain. These screens revealed a large collection of novel interaction partners ( Fig. 2A and Table 1 ), all of which pass high-stringency secondary yeast two-hybrid tests for both reproducibility and partner specificity [22] . To ensure that novel interactions involving CHMP proteins were not missed due to sampling effects, which are inherent in library screening methods, we also performed secondary targeted interaction studies in which 30 prey clones identified in our primary library screen were systematically retested against all CHMP proteins. Reassuringly ∼97% (29/30) of the interactions detected in primary library screens were reconfirmed in these reiterative matrix experiments. In addition, we detected a further 30 interactions that were not detected in primary screens. Interestingly prey clones that were isolated from CHMP1B, CHMP2A, CHMP5, and CHMP6 screens demonstrated strict fidelity for the original bait. In contrast some prey clones isolated from CHMP3, CHMP4A, CHMP4B, and CHMP4C screens showed broad, yet selective, interaction profiles ( Supplementary Fig. 1 ). Data from both library screens and targeted matrix experiments were combined to investigate the connectivity of our dataset. The resulting CHMP protein interaction network ( Fig. 2A ) depicts many novel features, which may be useful in guiding future research into both the nuclear and the cytoplasmic/endosomal functions of mammalian CHMP proteins. For example; it is interesting to note that we detected novel interactions between components of the ESCRT III complex and several proteins that may form part of signal transduction cascades. These include TRAF4AF1, which interacts with CHMP1B, and CC2D1A, which was found to interact with CHMP4A, 4B, and 4C. Also as CHMP1A has been shown to have a role in cell cycle progression and chromatin structure [20] it may be significant to note that at least 19 of the 45 novel interactions detected in this study involve proteins that have either known nuclear functions or nuclear-related (GO) ontology annotations (Table  1) . These include SSRP1 and SMARCA4, both of which are thought to be involved in chromatin remodeling. In addition it 
Protein interactions detected in 20 yeast two-hybrid library screens. Each human CHMP protein was used as a bait to screen both K562 and Fetal Brain yeast twohybrid prey libraries. The library from which each interaction was detected is indicated by a bold "X". Known Interlog interactions are indicated by the species in which the interaction was observed: SC, Saccharomyces cerevisiae; DM, Drosophila melanogaster. Gene Ontology (GO) terms extracted from GOA are shown for interaction partners with potential nuclear (N) functions or proteins that may be involved in some aspect of signal transduction (ST), cell cycle progression (CC), or chromatin remodeling (CH).
is potentially significant that several of the prey clones were recognized by multiple members of the CHMP family. These highly connected preys include the SUMO conjugating enzyme UBE2I, which was found to interact with CHMP1A, CHMP4B, and CHMP5. Significantly an interaction between CHMP4B and UBE2I was also detected in the recent largescale human interactome study performed by Rual et al. [23] .
To investigate if preys at the periphery of our network could be integrated into closed loops by the addition of further data we searched the HIMAP, HPRD, and NCBI databases to identify additional known interaction partners for each node in our network. As a result of extending our network in this way we were able to identify a new set of interconnected nodes, which contain functionally related proteins. Of particular interest was the formation of a network connecting CHMP1A, CHMP4B, and CHMP5 with UBE2I, SUMO1, PIAS2, and HIPK2 (Fig.  2B ), all of which are known to be involved in nuclear sumolation processes.
In addition we also found that RAB11A and AMSH/ STAMBP both interacted with multiple CHMP proteins. ( Fig.  2A and Supplementary Fig. 1 ). Although many of the observed interactions may provide clues to the potential nuclear and cytoplasmic functions of the different human CHMP proteins we were particularly interested in two putative interaction partners, both of which appeared to possess MITlike domains.
Additional MIT domain-containing proteins interact with components of the human ESCRT III complex
Analysis of the domain composition of novel CHMP interaction partners revealed two proteins, LOC129531 and AMSH/STAMBP, that have sequence motifs that resemble the MIT domains (IPR007330) of VPS4B [24] and spastin [25] , both of which bind to the human CHMP1B protein ( Fig. 2A) . Although the uncharacterized LOC129531 protein is known to contain an MIT domain, the human AMSH protein was not known to be a member of the MIT domain family. However, when the key MIT domain residues defined by Scott et al. [26] were aligned with the N-terminal region of the human AMSH protein (amino acids 34-113), we found that of the 38 consensus MIT domain residues, 4 were not conserved in either AMSH or the human VPS4B protein. However, of the remaining 34 residues, 22 (64%) were preserved in the human AMSH protein and a further 4 had conserved amino acid substitutions representing >76% conservation between the Nterminal region of the human AMSH protein and residues in the consensus MIT domain sequence (Fig. 3A) . Furthermore, analysis of the predicted helical nature of amino acids 34-113 of the human AMSH protein revealed three helical domains (Fig. 3A) , which resemble the pattern observed in known MIT domain structures [26] . These data strongly suggest that AMSH could be a new member of the human MIT domain family. As the MIT domains of VPS4A and spastin are both known to be required for interaction with CHMP proteins [25, 27] we performed a domain fragmentation study to determine which domains of the human AMSH protein were required for interaction with each of the human CHMP proteins. Domain analysis of the human AMSH protein identified five domain features, including MIT (IPR007330), MADS (IPR002100), COIL, Mov34 (IPR000555), and CON (connexin-like) domains (Fig. 3B) . Therefore the AMSH protein was fragmented into four fragments, which were designed to assess the requirement for each domain in AMSH/CHMP protein interaction. Unfortunately, fragment 1 (amino acids 1-104) exhibited mild autoactivation in yeast two-hybrid assays (Figs. 3C and 3D) . However, fragment 2 (amino acids 1-248) interacted strongly with CHMP1B, CHMP3, and CHMP4B. This fragment also showed weak interactions with CHMP4A and CHMP1A. This profile of selective interaction was very similar to that observed for the full-length AMSH protein. Interestingly, neither fragment 3 (amino acids 98-248) nor fragment 4 (amino acids 98-424) was capable of binding to any of the human CHMP proteins. Therefore, we predict that the N-terminal 100 amino acids are required for CHMP protein interaction. Significantly this is also the region that encodes the putative MIT domain.
Reciprocal yeast two-hybrid screening to identify novel AMSH-interacting proteins
To investigate further the interaction profile of the human AMSH protein we performed a reciprocal yeast two-hybrid screen in which the AMSH protein was used as a bait to screen a high-complexity human K562 prey library. This screen isolated 11 different prey proteins, each of which passed all of our reproducibility and specificity tests [22] . The prey proteins identified in this screen were GRB2 (GeneID: 2885), GRAP2 (GeneID: 9402), STAM 1 (GeneID: 8027), STAM2 (GeneID: 10254), UACA (Gene ID: 55075), CTNNBL1 (GeneID: 56259), CHMP3 (GeneID: 51652), ALAS1 (GeneID: 211), MAP2K5 (GeneID: 5607), AMN (GeneID: 81693), and CHMP1A (GeneID: 5119). Of these proteins GRAP2, STAM1, and STAM2 are known AMSH interaction partners, while GRB2, UACA, CTNNBL1, ALAS1, MAP2K5, AMN, and CHMP1A represent novel interactions. A conserved interlog interaction between CHMP3 and AMSH was also observed in Drosophila melanogaster [28] and CHMP3 has been shown to form an in vitro complex with AMSH and STAM [34] . To investigate whether AMSH/CHMP1A, AMSH/ CHMP3, and LOC129531/CHMP2A interactions could be observed in mammalian cells we then performed a range of complementary protein interaction experiments in human cells.
Colocalization of interaction partners in HeLa cells
To establish if potential interaction partners colocalize when coexpressed in mammalian cells, epitope-tagged versions of CHMP1B, CHMP3, and AMSH or CHMP2A and LOC129513 proteins were transiently expressed in HeLa cells and the relative distribution of partner proteins was analyzed by confocal microscopy. Data presented in Fig. 4 show that a partial yet distinct colocalization was observed between CHMP1B and AMSH (Figs. 4A-4C ), CHMP3 and AMSH ( Figs. 4D-4F) , and CHMP2A and the LOC120513 protein (Figs. 4G-4I ). In each case proteins were seen to be colocalized on punctate vesicular structures.
Having established that both AMSH and LOC120531 colocalize with their putative CHMP binding partners, we then performed protein complementation assays to demonstrate that each of these putative interactions can take place in live human cells. For this purpose we employed the split β-lactamase system [29, 30] . This approach has previously been used to study a range of protein interactions in live human cells, including an interaction between CHMP1B and the MIT domain-containing protein spastin [25] . To assess the degree and specificity of each putative interaction cells were cotransfected with either a combination of predicted interaction partners (CHMP1B/AMSH, CHMP3/AMSH, or CHMP2A/ LOC129531) or combinations of inappropriate interaction partners (ATP6G/CHMP1B, ATP6G/CHMP3, ATP6G/ CHMP2A, ATP6E/LOC129531, or ATP6E/AMSH). In addition cells were also transfected with two known interaction partners (ATP6G and ATP6E) or vectors containing only the two complementary β-lactamase fragments. Results from these experiments show that when each of our predicted interaction pairs, CHMP1B/AMSH, CHMP3/AMSH, and CHMP2A/ LOC219531, was coexpressed we detected significantly more cells expressing reconstituted β-lactamase activity than was observed when either interaction partner was coexpressed with an inappropriate interaction partner (Figs. 5A-5C ). Moreover interaction levels observed between predicted interaction pairs were always far greater than background levels observed when complementary β-lactamase fragments were expressed alone (Figs. 5B-5D ). Finally, although the absolute number of β-lactamase-positive cells varied between independent experiments the relative proportion of positive cells observed for true interaction partners compared to that observed for negative control or inappropriate pairings was comparable directly between independent experiments (Fig. 5D) .
Coprecipitation of CHMP2A/LOC129531, CHMP1B/AMSH, and CHMP3/AMSH complexes from transiently transfected cells
To substantiate further our colocalization and split β-lactamase data, we performed coprecipitation experiments to demonstrate that each of the three CHMP proteins (1B, 2A, and 3) could be immunopurified with its respective binding partner following transient coexpression in mammalian cells. This was achieved by coexpressing one partner as an EGFP fusion and the other partner as a cmyc fusion (Fig. 6) . Following cell lysis EGFP fusion proteins were precipitated using an anti-EGFP polyclonal antiserum and the degree of association between EGFP and the cmyc-tagged partner protein was assessed by Western blotting using a monoclonal anti-cmyc antibody. In each case control coprecipitations were also performed in which cmyc-tagged proteins were coexpressed with EGFP alone. Data presented in Fig. 6 show that cmyc-tagged proteins were coprecipitated only when expressed with the predicted interaction partner fused to EGFP and not when coexpressed with EGFP alone. Collectively data from these three different interaction studies provide strong evidence that the predicted interactions between CHMP1B/AMSH, CHMP3/AMSH, and CHMP2A/LOC129531 may well be physiologically relevant.
As such these data demonstrate that two further MIT domaincontaining proteins are recruited to the ESCRT III complex in mammalian cells. Finally, as CHMP proteins are known to localize to either late or distended hybrid endosomes we compared the distribution of individual interaction partners with that of the M6PR protein, which is known to localize to late endosomes. In each case we observed a partial colocalization of CHMP1B, CHMP3, AMSH, and LOC129531 with M6PR-positive membranes, implying that the observed interactions between CHMP proteins and MIT domaincontaining proteins may in part occur on late endosomal membranes (Fig. 7) .
Discussion
Although the basic principles of MVB formation appear to be conserved through evolution, there has been a significant expansion in proteome complexity between yeast and mammals. In addition, mammalian cells have evolved specialized adaptations of MVB function [4] [5] [6] . As such, extrapolation of data from model organisms may provide an incomplete view of the molecular mechanism of MVB formation in mammalian cells. For example, the occurrence of three forms of CHMP4 (Vps32p/Snf7p), two forms of CHMP2 (Vps2p), and two forms of CHMP 1 (Did2p) in mammalian cells raises the issue of how these additional components assemble to form the human ESCRT III complex. As yet, it is not clear if all 10 mammalian ESCRT III components assemble into a distinct structure with invariant composition or stoichiometry.
Data from our yeast two-hybrid studies support and extend previous studies [9, 10] , which show that direct interactions can occur between the different CHMP protein isoforms, including CHMP1A and CHMP1B and different combinations of the CHMP4 proteins. Therefore, it is possible that rather than being mutually exclusive, the extra forms of each CHMP protein may associate within the same complex. This possibility is supported by the fact that transiently expressed forms of CHMP1A and CHMP1B and combinations of the different CHMP4 proteins colocalize to common subcellular structures in mammalian cells (Supplementary Fig. 2 ). Given the diversity of mammalian cell types it was also possible that CHMP isoforms may be expressed in different cell types. However, analysis of the expression patterns of all 10 human CHMP transcripts in a range of human cells and tissues shows that both forms of CHMP1 and CHMP2 are coexpressed in the same cell. Equally, multiple forms of CHMP4 are frequently expressed in the same cell or tissue, although CHMP4C is frequently expressed at a very low level compared to the other two isoforms (Supplementary Fig. 3 ). Therefore at present it would appear that different CHMP isoforms may exist in the same ESCRT complex. However, we cannot yet rule out the possibility that multiple ESCRT complexes with different core components In each case cells were prepared for immunoprecipitation 24 h after transfection. EGFP-tagged proteins were precipitated from soluble extracts using a polyclonal anti-EGFP antibody (+) before being processed for Western blotting. The presence of associated myc-tagged proteins was then analyzed by Western blotting with a monoclonal anti-cmyc antibody. In each case mock precipitations were performed in the absence of the anti-EGFP antibody (−). For each precipitation reaction the expression levels of input proteins were analyzed to ensure comparable starting expression levels (Input).
and/or associated auxiliary factors may exist within the same cell. Clearly this type of combinatorial system could increase the fidelity and range of protein sorting of recycling events.
Our data also show that several of the human CHMP proteins can form homodimers, in addition to interacting with other CHMP proteins and a range of noncore auxiliary factors. As such, it is not yet clear what determines partner preferences in vivo. It is possible that CHMP-CHMP partner preference may be determined by differential binding affinities as observed for the organization of structurally related proteins within the human LSM ring complexes [31] . Equally, homodimerization could also prevent heterotypic CHMP-CHMP interactions, thereby regulating ESCRT III assembly or membrane association as proposed for the VPS4 proteins [27] . Alternatively, homo-and heterotypic interactions may utilize different interaction surfaces. Given the similarity of the different CHMP proteins the latter possibility may seem less probable; however, the observation that CHMP5 homodimers were observed when both N-and C-terminal yeast two-hybrid GAL4BD fusions were used, whereas interaction between CHMP5 and other CHMPs could be detected only when Nterminal GAL4BD constructs were used, implies that at least for CHMP5 this possibility cannot yet be totally discounted.
Unlike all other CHMP proteins no interaction has yet been observed between CHMP5 and VPS4AP; however, CHMP5 does interact with Vta1. The proposed structure of the VPS4AP/ VTA1 complex depicts two stacked rings of six VPS4A proteins, each with a peripheral band of six VTA1 proteins [27] . It is therefore possible that the role of CHMP5 is to tether or in some way regulate the assembly or function of the VPS4/VTA1 complex, whereas other CHMP proteins may interact only with the VPS4 protein core as they are extruded from the membrane.
As some CHMP proteins have both a nuclear and a cytoplasmic distribution it is feasible that different partner preferences may be exhibited in different subcellular compartments. Interestingly a significant number of prey proteins identified in our yeast two-hybrid screens have known or predicted nuclear functions. In particular we identified a group of interaction partners including HIPK2, PIAS2, and UBE2I (Fig. 2B) , all of which are known to be involved in the sumolation of nuclear proteins. In this respect it is intriguing to note that Stauffer et al. [20] have shown that nuclear forms of CHMP1A are in some way posttranslationally modified. As several of the human CHMP proteins do have consensus sumolation sequences it is possible that UBE2I may play a role in regulating the function of CHMP proteins within the nucleus of human cells.
One of the primary aims of this study was to use a systematic yeast two-hybrid approach to identify novel binding partners, which may provide new insights into the process of MVB formation in mammalian cells. Interestingly, studies in yeast suggest that the ubiquitin-conjugating enzyme UBC13 is in some way required for the internalization of surface receptors. By extrapolation this in turn implicates a role for K63-linked ubiquitin chains in receptor internalization and degradation. Recent studies provide direct evidence that this prediction is correct in human cells [36] . However, how components of the human ESCRT III complex engage or disengage K63-linked proteins remains unclear. The ability of multiple ESCRT III proteins to recruit the AMSH protein, which is known to be an endosome-associated ubiquitin isopeptidase with the ability to cleave K63-linked ubiquitin chains [32] , implies that the presence or absence of K63 chains may affect the ultimate fate of some internalized surface receptor proteins. In this respect it is interesting to note that UBC13 and AMSH were both identified as suppressors of the Ste12Δ phenotype, which results from defects in vesicular transport and the formation of distended vacuoles [33] .
Although the AMSH/CHMP3 interaction is conserved between Drosophila and mammals, our data show that in human cells AMSH binds to a distinct subset of ESCRT III components, with robust interactions also occurring between CHMP1A and CHMP1B and CHMP4A (Fig. 3) . The recruitment of two further MIT domain-containing proteins to the human ESCRT III complex raises several interesting issues. To date five MIT domain-containing proteins have been found to interact with components of the human ESCRT III complex ( Fig. 2A) . However, as several MIT domain proteins exhibit an ability to bind to the same CHMP protein it will be important to determine if the binding of different endogenous MIT domaincontaining proteins is antagonistic or if multiple MIT domaincontaining proteins can be recruited to the same ESCRT complex. Also, as each MIT domain protein appears to interact with only a subset of CHMP proteins, a more detailed dissection of these interactions is required to explain the specificity of MIT domain-CHMP interactions. At present it would appear that the ESCRT III complex may facilitate the recruitment of a diverse set of functionally distinct MIT domain-containing proteins, some of which may have antagonistic functions.
Although there are still many aspects of MVB formation and CHMP protein function that remain unanswered, data presented in this report provide a more comprehensive insight into the spectrum of potential CHMP protein interactions. As such these data will provide potentially important leads to characterizing new pathway components, defining interaction specificities, and guiding future research into multiple aspects of the precise function of different human CHMP proteins.
Materials and methods
Construction of yeast two-hybrid bait and prey clones
Complete open reading frames of the 10 human CHMP proteins were amplified by PCR using the proofreading enzyme Platinum Pfx polymerase (Invitrogen). The GenBank/RefSeq accession numbers and IMAGE IDs for each clone are as follows: CHMP1A, AF281063:3507057; CHMP1B, AF281064: 3928338; CHMP2A, AF042384:3051024; CHMP2B, AF151842:3460712; CHMP3, AF219226:3660116; CHMP4A, AF161483:4295071; CHMP4B, NM_176812:5173394; CHMP4C, NM_152284:3828410; CHMP5, AF132968:4044464; CHMP6, NM_024591:3604039. With respect to the nomenclature of human CHMP proteins, it is important to note that the nomenclature used in this article for human CHMP4A and CHMP4B is in accordance with the current annotation of the human genome, which is the reverse of that used in previous publications [9, 10] , in which CHMP4A was assigned the accession number NM_176812:5173394 and CHMP4B AF161483: 4295071. In each case primers were designed from the reference mRNA sequence and were tagged at the 5′ end with GATEWAY recombination cloning sequences. PCR products were then cloned by the gap-repair recombination method into the GATEWAY-compatible bait vector pGBAD-B or pB-GBD and the equivalent prey vector pACTBD-B or pB-ACT2. All bait constructs were assembled in the PJ69-4A MATa strain, while prey constructs were assembled in the complementary mating type switched strain PJ69-4A MATα. Targeted matrix experiments were performed as described previously [31] .
Yeast two-hybrid library screens
Library screens were performed as described previously [22] .
Immunofluorescence
HeLa cells were seeded onto sterile glass coverslips in six-well plates at an approximate density of 0.5 × 10 5 cells/well. After an overnight incubation cells were transfected with 400 ng of vector DNA in combination with Effectene transfection reagent (Qiagen), in accordance with the manufacturer's instructions. Transfected cells were incubated for either 24 or 48 h in DMEM (Life Technologies) containing 10% fetal bovine serum (Sigma), 100 U/ml penicillin and 100 mg/ml streptomycin (Sigma), and 2 mM Lglutamine (Sigma). Cells were then washed in PBS (Sigma) prior to being fixed at room temperature for 15 min in 4% formaldehyde/PBS. Fixed cells were then washed in PBS before being permeabilized in PBS/0.1% Triton X-100 (Sigma) for 5-10 min at room temperature. Following permeabilization cells were washed three times in PBS before being incubated in blocking solution (PBS, 10% FBS). Where appropriate cells were stained using a primary mouse monoclonal anti-cmyc antibody followed by a rabbit polyclonal anti-M6PR. After being washed three times in blocking buffer cells were incubated with a Cy3-conjugated anti-mouse or anti-rabbit secondary antibody (Jencons) as appropriate. In each case secondary antisera were used at a dilution of 1/300 in blocking buffer. Following staining coverslips were sequentially washed in PBS and distilled H 2 O before being mounted in Vectorshield (Vector Laboratories, Inc.).
Coimmunoprecipitation experiments
Approximately 1 × 10 5 HEK293T cells were cotransfected with the desired combination of EGFP and cmyc-tagged fusion proteins. To control for interaction specificity each myc-tagged protein was also independently cotransfected with a comparable plasmid expressing only EGFP. At 24 h postinfection cells were washed twice with PBS before being lysed in 600 μl of ice-cold lysis buffer containing 1% (v/v) NP-40, 150 mM NaCl, 10 mM TrisHCl (pH 7.5), 0.02% sodium azide, 1 mg/ml BSA, and 0.5% protease inhibitor cocktail. A 100-μl aliquot of the total lysate was removed to assess relative expression levels and the remaining lysate was centrifuged at 13,000g for 15 min at 4°C. The resulting soluble fraction was then removed and extracts were incubated overnight at 4°C with rabbit polyclonal anti-GFP primary antibody (Abcam) at a concentration of 1:250. Protein A-Sepharose beads (50 μl of a 50% slurry per reaction) were then added and samples were incubated at 4°C for a further 2 h. Beads were then isolated by brief centrifugation before being washed three times in NP-40 buffer containing BSA and then in NP-40 buffer without BSA. Beads were then resuspended in 5× SDS-PAGE sample buffer and heated for 5 min at 95°C. Bound proteins were then resolved by standard SDS-PAGE before being transferred to membranes for Western blot analysis. Blots were stained using mouse monoclonal anti-myc clone 4A6 primary antibody (Upstate) at a concentration of 1:250.
Split β-lactamase protein complementation assays GATEWAY compatible split-component β-lactamase expression vectors were constructed as described previously (HMG 1). HEK293T cells were split 24 h prior to transfection and seeded at a density of 2.5 × 10 5 cells per well in two-well glass chamber slides (Nunc Lab-Tech II Chamber Slide System) in DMEM/10% FBS, 1% penicillin and streptomycin. In each case cells were transfected with ∼300 ng of plasmid DNA using Effectene (Qiagen) according to the manufacturer's instructions. At 48 h posttransfection cells were washed once and resuspended in 750 μl of Hanks' balanced salt solution (Life Technologies). The relative level of reconstituted β-lactamase activity was then assessed using the GeneBLAzer detection kit (Invitrogen) according to the manufacturer's instructions. Following addition of the cells permeable substrate CCF2/AM cells were incubated for 1 h in the dark before being analyzed by fluorescence microscopy using an Olympus IX81 inverted epifluorescence microscope fitted with a 40× objective. Simultaneous acquisition of two-color fluorescence was performed in real time using a 400DF15 excitation filter and dual-view imaging system (Optical Insights) containing a filter cube with both 450DF65 and 535DF35 emission filters (OMEGA Optical). Cell R imaging software (Olympus) was used for the analysis of multicolor images. The relative proportion of cells expressing reconstituted β-lactamase activity was assessed by counting the number of blue (positive) and green (negative) cells in 10 random fields of view from each slide.
